Aidoc's AI proven to reduce PE hospital stay and enhance treatment access

Health institutions using Aidoc’s AI-driven pulmonary embolism (PE) care revealed groundbreaking research findings at the 9th Annual Pulmonary Embolism Symposium. The company collaborated with esteemed organisations, including the University of Texas Medical Branch, Jamaica Hospital Medical Center, and the University of Chicago, Aidoc's PE AI solution demonstrated remarkable clinical benefits.

The University of Texas Medical Branch (UTMB) showcased how Aidoc's AI platform, aiOS™, helped operationalise PE workflows and improve patient outcomes. Their research revealed significant reductions in ICU and hospital length of stay following the implementation of Aidoc's AI-powered PERT solution.

At Jamaica Hospital Medical Center, Aidoc's integration in the PERT workflow resulted in a 68% increase in PE patients referred for interventional therapies, emphasising its impact even when PERT is available. The University of Chicago Department of Medicine demonstrated Aidoc's PE AI's retrospective predictive power, achieving a 95% sensitivity in identifying patients requiring advanced therapy.

Jerome Avondo, VP of Clinical Affairs and Reimbursement at Aidoc, emphasised the importance of scientific rigor and peer review in validating AI solutions. These findings underscored the multifaceted benefits that AI can offer patients, healthcare providers, and health systems in managing complex, high-acuity patient populations like PE.

Aidoc's AI-powered PE solution has evolved into an enterprise-wide platform used by Pulmonary Embolism Response Teams (PERTs) across entire health systems. It operates continuously, examining CT exams and bringing suspected findings to care teams faster. The solution streamlines workflows and communications, automating notifications and prioritising CT imaging to aid radiologists in triaging and coordinating treatment.

Click here to read the original news story.